Large New Zealand Survey Finds 60% of Cannabis Users Report Using Less Alcohol and Synthetic Cannabinoids

Sixty percent reported cannabis use led to less alcohol use, 60% to less synthetic cannabinoid use, 44% to less morphine use, and 40% to less methamphetamine use. Cannabis had no impact on LSD, MDMA, or cocaine use for about 70% of co-users. One in five reported cannabis led to more tobacco use. Young adults (21-35) and Maori were more likely to report substitution.

Online convenience survey promoted via Facebook, completed by 23,500 New Zealand respondents. Those who co-used cannabis and any of eight other substances in the same six-month period rated cannabis's impact on their other substance use. Frequency and quantity were compared across groups. Generalized logistic regression modeled predictors.

The cannabis substitution debate has real policy implications: if cannabis replaces more dangerous substances for some populations, restriction policies may inadvertently increase harm. This is among the largest studies to document substitution patterns and, critically, to show these patterns differ by demographic group.

Cannabis policy often assumes a "gateway" model where cannabis leads to more drug use. This large-scale evidence from New Zealand supports an alternative model for many users: cannabis as a substitute that reduces use of potentially more harmful substances, particularly alcohol, opioids, and methamphetamine.

Convenience sample recruited via Facebook is not representative of all cannabis users. Self-reported substitution effects may reflect perceived rather than actual changes. Cross-sectional data cannot establish causal direction. New Zealand's drug market may differ from other countries.